HCPCS 2018
| A9542 | Indium in-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries | |
| Added on: Sunday, January 01, 2006 | ||
| Status changed on: Sunday, January 01, 2006 | ||
| BETOS Classification : Standard imaging - nuclear medicine | ||
| Medicare coverage status:Carrier judgment | ||
Medical Codes
